OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
July 28, 2023
Pandemic preparedness and curbing PBMs among the pending legislation that will have to wait until after summer recess.
July 21, 2023
The agency proposes significant revisions to oversight programs for drugs and medical products.
July 06, 2023
Recent lawsuits are challenging the constitutionality of provisions in the Inflation Reduction Act.
June 06, 2023
Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.
May 12, 2023
Amid drug pricing blame game, Congress advancing a range of reform efforts to manage and curb pharmacy benefit manager practices.
March 24, 2023
Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.